文献速递疝与腹壁外科围术期管理与 ERAS

择期腹股沟疝修补术后患者自报阿片类镇痛药需求:呼吁制定手术特异性阿片类药物给药策略

Patient-reported opioid analgesic requirements after elective inguinal hernia repair: A call for procedure-specific opioid-administration strategies.
PubMed 文献 · Surgery · 2017-08-01

本研究为前瞻性观察性研究,于2015年10月至2016年9月在单外科医生高产量的腹股沟疝手术实践中,纳入185例在局部麻醉加静脉镇静下接受择期腹股沟疝修补术的成人患者,术后均开具10片阿片类镇痛药并建议仅用于非阿片类镇痛药无法控制的疼痛。结果显示85.9%患者使用≤4片,59.5%未使用任何阿片类镇痛药,未使用阿片类药物者疼痛干扰更少。

要点

  • 择期腹股沟疝修补术后多数患者阿片类镇痛药需求低,59.5%未使用任何阿片类药物。
  • 85.9%患者使用≤4片阿片类镇痛药,无人术后7天内仍在服用阿片类药物。
  • 未使用阿片类药物者腹股沟区最大疼痛和持续性疼痛更轻,日常活动受干扰更少。

核心结论

  • 多数患者报告不需要任何阿片类镇痛药,几乎所有认为需要者使用少于5片。
  • 在局部麻醉加静脉镇静下择期腹股沟疝修补术中,低阿片类镇痛药处方策略是可行的。

研究设计与样本

  • 前瞻性观察性研究,2015年10月1日至2016年9月30日单外科医生高产量腹股沟疝手术实践。
  • 纳入185例在局部麻醉加静脉镇静下接受择期腹股沟疝修补术的成人患者,术后均开具10片阿片类镇痛药。
  • 术后2至3周随访时通过问卷收集患者体验。

主要发现

  • 185例患者中,男性177例(95.7%),≥60岁96例(51.9%)。
  • 159例(85.9%)报告使用≤4片阿片类镇痛药,110例(59.5%)报告术后未使用任何阿片类镇痛药。
  • 无患者在术后预约时(术后7天内)仍服用阿片类药物。
  • 147例在职患者中,111例(75.5%)报告缺勤≤3个工作日,其中57例(51.4%)未缺勤。
  • 在职患者更可能术后使用阿片类镇痛药(P = .049);未使用阿片类镇痛药者最大腹股沟区疼痛(P < .001)和持续性腹股沟区疼痛(P = .037)更轻,疼痛对日常活动(P = .012)和休闲活动(P = .018)干扰更少。

临床怎么用

  • 择期腹股沟疝修补术后可考虑低阿片类镇痛药处方策略,如开具10片并建议仅用于非阿片类镇痛药无法控制的疼痛。
  • 应加强患者教育,鼓励优先使用非阿片类镇痛药,并告知多数患者可能不需要阿片类药物。

局限性

  • 研究为单外科医生、单中心实践,结果外推需谨慎。
  • 患者均接受局部麻醉加静脉镇静,未涵盖其他麻醉方式。
  • 阿片类药物使用情况基于患者自报问卷,可能存在回忆偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A better understanding of the analgesia needs of patients who undergo common operative procedures is necessary as we address the growing opioid public health crisis in the United States. The aim of this study was to evaluate patient experience with our opioid prescribing practice after elective inguinal hernia repairs. METHODS: A prospective, observational study was conducted between October 1, 2015, and September 30, 2016, in a single-surgeon, high-volume, practice of inguinal hernia operation. Adult patients undergoing elective inguinal herniorrhaphy under local anesthesia with intravenous sedation were invited to participate. All patients were prescribed 10 opioid analgesic tablets postoperatively and were counseled to reserve opioids for pain not controlled by nonopioid analgesics. Their experience was captured by completing a questionnaire 2 to 3 weeks postoperatively during their postoperative visit. RESULTS: A total of 185 patients were surveyed. The majority of the participants were males (177, 95.7%) and ≥60 years old (96, 51.9%). Of the 185 patients, 159 (85.9%) reported using ≤4 opioid tablets; 110 patients (59.5%) reported that they used no opioid analgesics postoperatively. None of the patients was taking opioids within 7 days of their postoperative appointment. Of the 147 patients who were employed, 111 (75.5%) reported missing ≤3 work days, 57 of whom (51.4%) missed no work at all. Patients who were employed were more likely to take opioid analgesics postoperatively (P = .049). Patients who took no opioid analgesics experienced less maximum (P < .001) and persistent groin pain (P = .037). Pain interfered less with daily activities (P = .012) and leisure activities (P = .018) for patients who did not use opioids. CONCLUSION: The majority of our patients reported that they did not require any opioid analgesics, and nearly all of those who thought that they did need opioids used <5 tablets. Our data suggest that for elective inguinal hernia repair under a local anesthetic with intravenous sedation, a policy of low opioid analgesic prescribing is achievable; these findings call for further investigation of how to best prescribe opioid medications to patients after an inguinal herniorrhaphy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Mylonas KS, Reinhorn M, Ott LR, et al. Patient-reported opioid analgesic requirements after elective inguinal hernia repair: A call for procedure-specific opioid-administration strategies. Surgery. 2017. PMID: 28778580. doi:10.1016/j.surg.2017.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。